Literature DB >> 1510677

PDGF AA homodimers are potent chemoattractants for fibroblasts and neutrophils, and for monocytes activated by lymphocytes or cytokines.

D Shure1, R M Senior, G L Griffin, T F Deuel.   

Abstract

The A-chain homodimers of the platelet-derived growth factor (PDGF AA) are widely expressed in normal and transformed cells. The mitogenic properties of PDGF AA are well established; however, the chemotactic potential of PDGF AA remains controversial. We now show that PDGF AA is a strong chemoattractant for human monocytes, granulocytes, and fetal bovine ligament fibroblasts. However, highly purified (greater than 98%) monocytes require the addition of lymphocytes or IL-1 for chemotactic responsiveness to PDGF AA but not for full chemotactic activity with formyl-methionyl-leucyl-phenylalanine (fMLP) or C5a. These results indicate that PDGF AA is a potent chemoattractant. These results also indicate that monocytes require activation either by lymphocytes or exogenous cytokines in order to respond chemotactically to PDGF AA but not to fMLP or C5a and suggest roles of the lymphocyte and cytokine in the chemotactic response of the monocyte to PDGF AA in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510677     DOI: 10.1016/s0006-291x(05)81577-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration.

Authors:  Anthony D Metcalfe; Mark W J Ferguson
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

2.  VEGFR2 survival and mitotic signaling depends on joint activation of associated C3ar1/C5ar1 and IL-6R-gp130.

Authors:  Ming-Shih Hwang; Michael G Strainic; Elliot Pohlmann; Haesuk Kim; Elzbieta Pluskota; Diana L Ramirez-Bergeron; Edward F Plow; M Edward Medof
Journal:  J Cell Sci       Date:  2019-03-28       Impact factor: 5.285

Review 3.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

4.  A quantitative method for determination of endothelial mRNA expression in vivo: induction of platelet-derived growth factor by endotoxin.

Authors:  J Taguchi; C E Murry; B I Herren; M Pech; S M Schwartz; V Lindner
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

5.  The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/- mice.

Authors:  Jingjing Tang; Koichi Kozaki; Andrew G Farr; Paul J Martin; Per Lindahl; Christer Betsholtz; Elaine W Raines
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

6.  In vivo tracking of mesechymal stem cells using fluorescent nanoparticles in an osteochondral repair model.

Authors:  Jong Min Lee; Byung-Soo Kim; Haeshin Lee; Gun-Il Im
Journal:  Mol Ther       Date:  2012-04-10       Impact factor: 11.454

7.  alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy.

Authors:  Renata Alleva; Marco Tomasetti; Davide Sartini; Monica Emanuelli; Emanuele Nasole; Ferruccio Di Donato; Battista Borghi; Lory Santarelli; Jiri Neuzil
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

8.  Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA.

Authors:  B D Levy; S Bertram; H H Tai; E Israel; A Fischer; J M Drazen; C N Serhan
Journal:  Lipids       Date:  1993-12       Impact factor: 1.880

9.  Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds.

Authors:  G F Pierce; J E Tarpley; J Tseng; J Bready; D Chang; W C Kenney; R Rudolph; M C Robson; J Vande Berg; P Reid
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  Hyaluronan based porous nano-particles enriched with growth factors for the treatment of ulcers: a placebo-controlled study.

Authors:  B Zavan; V Vindigni; K Vezzù; G Zorzato; C Luni; G Abatangelo; N Elvassore; R Cortivo
Journal:  J Mater Sci Mater Med       Date:  2008-08-30       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.